This work was supported by funding from the Beijing Natural Science Foundation
(Grant No. JQ21022), National Natural Science Foundation of China (Grant No.
82071212, 81901181, and 12026414), and Beijing Ten Thousand Talents Project
(Grant No. 2020A15). This work was also partially supported by funding from the
Science and Technology Beijing One Hundred Leading Talent Training Project
(Z141107001514006), the Beijing Municipal Administration of Hospitals’ Mission Plan
(SML20150802), the Funds of Academic Promotion Programme of Shandong First
Medical University & Shandong Academy of Medical Sciences (No. 2019QL016, No.
2019PT007)
第一作者机构:[1]Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Lab Brain Disorders,Minist Sci & Technol, Beijing 100069, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Inst Brain Disorders, Collaborat Innovat Ctr Brain Disorders, Lab Brain Disorders,Minist Sci & Technol, Beijing 100069, Peoples R China[2]Chinese Inst Brain Res, Beijing 102206, Peoples R China[7]Wannan Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, 22 Wenchang Rd, Wuhu 241002, Anhui, Peoples R China[8]Wannan Med Coll, Inst Chron Dis Prevent & Control, 22 Wenchang Rd, Wuhu 241002, Anhui, Peoples R China[9]Capital Med Univ, Xuanwu Hosp, Beijing Key Lab Hypoxia Translat Med, Beijing Key Lab Translat Med Cerebrovasc Dis,Natl, Beijing 100053, Peoples R China[10]Shengli Oilfield Cent Hosp, Brain Hosp, Dongying 257000, Shandong, Peoples R China
推荐引用方式(GB/T 7714):
Gao Shan,Zhu Ping,Wang Tao,et al.Alzheimer's disease genome-wide association studies in the context of statistical heterogeneity[J].MOLECULAR PSYCHIATRY.2024,doi:10.1038/s41380-024-02654-x.
APA:
Gao, Shan,Zhu, Ping,Wang, Tao,Han, Zhifa,Xue, Yanli...&Liu, Guiyou.(2024).Alzheimer's disease genome-wide association studies in the context of statistical heterogeneity.MOLECULAR PSYCHIATRY,,
MLA:
Gao, Shan,et al."Alzheimer's disease genome-wide association studies in the context of statistical heterogeneity".MOLECULAR PSYCHIATRY .(2024)